ENDRA Life Sciences Inc. — Director's Dealing 2017

Jun 28, 2017

SEC Form 4/A — Form 4/A

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2017-06-09

Reporting Person: Michelon Francois Roger (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-09	Stock Options	$4.55	A	31960	Acquired	2025-05-12	Common Stock (31960)	Direct

Footnotes

F1: These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

F2: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.